Adult Schedule
The recommended healthcare preventive needs are constantly changing. For example, an annual physical/medical examination is not always recommended or necessary. Although your personal health could impact these recommendations, the schedules below can help recommend the services that should be considered based upon your age.
-
Screening Recommendations for Females: 21-39 Years
Screening, immunization, and prevention schedule for asymptomatic average-risk women: 21-39 Years
These screening recommendations are driven by Mayo Clinic consensus and incorporate — but do not exactly replicate — screening guidelines from the U.S. Preventive Services Task Force and other organizations.
Screening Recommendations Alcohol abuse Every year Cervical cancer Ages 21 to 24 years: every 3 years
Ages 25 to 39 years: every 3 to 5 years
Colorectal cancer Begin if increased risk Depression Every year Diabetes (Type 2) Every 3 years if hypertension (BMI > 25 in Asian patients) Hepatitis C One-time screen for all adults age 18 to 79 years HIV At least one lifetime screen for all age groups Hyperlipidemia (coronary artery disease) Screen initially at age 20 years, then resume no later than age 40 years Hypertension Every 2 years Intimate partner violence Every year Obesity Every 2 years Sexually transmitted infections (chlamydia, gonorrhea, syphilis) Age < 25 years: Every year if sexually active
Tobacco use Every year Vaccinations for healthy women COVID-19 Primary series and bivalent booster Hepatitis B Everyone through age < 59 years Human papillomavirus (HPV) Initiate series for adults up through age 26 years, consider series initiation for ages 27 through 45 years based on shared decision-making; HPV vaccine is not recommended in pregnant women Influenza Every year Tetanus, diphtheria, acellular pertussis (Tdap and Td) If primary series of Tdap/DTaP has been completed at any age, boost with Tdap every 10 years Other adult vaccinations Consider varicella, hepatitis A, hepatitis B, measles-mumps-rubella, meningococcal ACWY and meningococcal B vaccines depending on age and risk factors -
Screening Recommendations for Females: 40-49 Years
Screening, immunization, and prevention schedule for asymptomatic average-risk women: 40-49 Years
These screening recommendations are driven by Mayo Clinic consensus and incorporate — but do not exactly replicate — screening guidelines from the U.S. Preventive Services Task Force and other organizations.
Screening Recommendations Alcohol abuse Every year Breast Cancer Every year Cervical cancer Every 3 to 5 years Colorectal cancer If age < 45 years, consider if increased risk
Consider beginning screening of average-risk patients at age 45 years
Depression Every year Diabetes (Type 2) Every 3 years beginning at age 45 years Hepatitis C One-time screen for all adults ages 18 to 79 years HIV At least one lifetime screen for all age groups Hyperlipidemia (coronary artery disease) Every 4 to 6 years Hypertension Every year Intimate partner violence Every year Obesity Every 2 years Sexually transmitted infections (chlamydia, gonorrhea, syphilis) Every year if sexually active
Tobacco use Every year Vaccinations for healthy women COVID-19 Primary series and bivalent booster Hepatitis B Everyone through age < 59; consider for age > 60 depending on risk factors Human papillomavirus (HPV) Initiate series for adults up through age 26 years, consider series initiation for ages 27 through 45 years based on shared decision-making; HPV vaccine is not recommended in pregnant women Influenza Every year Tetanus diphtheria, acellular pertussis (Tdap and Td) If primary series of Tdap/DTaP has been completed at any age, boost with Tdap every 10 years Other adult vaccinations Consider varicella, hepatitis A, hepatitis B, measles-mumps-rubella, meningococcal ACWY and meningococcal B vaccines depending on age and risk factors -
Screening Recommendations for Females: 50-64 Years
Screening, immunization, and prevention schedule for asymptomatic average-risk women: 50-64 Years
These screening recommendations are driven by Mayo Clinic consensus and incorporate — but do not exactly replicate — screening guidelines from the U.S. Preventive Services Task Force and other organizations.
Screening Recommendations Alcohol abuse Every year Breast Cancer Every year Cervical cancer Every 3 to 5 years Colorectal cancer Continue average-risk screening Depression Every year Diabetes (Type 2) Every 3 years Hepatitis C One-time screen for all adults ages 18 to 79 years HIV At least one lifetime screen for all age groups Hyperlipidemia (coronary artery disease) Every 4 to 6 years Hypertension Every year Intimate partner violence Every year Obesity Every 2 years Sexually transmitted infections (chlamydia, gonorrhea, syphilis) Every year if sexually active Tobacco use Every year Vaccinations for healthy women COVID-19 Primary series and bivalent booster Hepatitis B Everyone through age < 59; consider for age > 60 depending on risk factors Herpes zoster or shingles (HZV) 2 doses of Shingrix (regardless of previous Zostavax) at age > 50 years unless contraindicated Influenza Every year Tetanus diphtheria, acellular pertussis (Tdap and Td) If primary series of Tdap/DTaP has been completed at any age, boost with Tdap every 10 years Other adult vaccinations Consider varicella, hepatitis A, hepatitis B, measles-mumps-rubella, meningococcal ACWY and meningococcal B vaccines depending on age and risk factors -
Screening Recommendations for Females: 65 and older
Screening, immunization, and prevention schedule for asymptomatic average-risk women: 65 years and older
These screening recommendations are driven by Mayo Clinic consensus and incorporate — but do not exactly replicate — screening guidelines from the U.S. Preventive Services Task Force and other organizations.
Screening Recommendations Alcohol abuse Every year Breast Cancer Ages 65 to 75 years: every year Cervical cancer No screening after age 65 if adequate negative prior screening and patient not at high risk Colorectal cancer Ages 65 to 75 years (life expectancy > 10 years): Continue screening
Ages 76 to 85 years (life expectancy > 10 years): Screen patients who have never been screened; continued screening of other patients has uncertain benefit
Depression Every year Diabetes (Type 2) Every 3 years Fall risk Every year Hepatitis C One-time screen for all adults age 18 to 79 years HIV At least one lifetime screen for all age groups Hyperlipidemia (coronary artery disease) Ages 65 to 75 years: Consider every 4 to 6 years Hypertension Every year Intimate partner violence Every year Obesity Every 2 years Osteoporosis and osteopenia Screening bone density measurement at age 65 years Sexually transmitted infections (chlamydia, gonorrhea, syphilis) Every year if sexually active Tobacco use Every year Vaccinations for healthy women COVID-19 Primary series and bivalent booster Hepatitis B Consider for age > 60 depending on risk factors Herpes zoster or shingles (HZV 2 doses of Shingrix (regardless of previous Zostavax) at age > 50 years unless contraindicated Influenza Every year Pneumococcal One-time dose of PCV20 at age 65 if no previous pneumococcal vaccination; if previous pneumococcal vaccination received, please check with your clinician Tetanus diphtheria, acellular pertussis (Tdap and Td) If primary series of Tdap/DTaP has been completed at any age, boost with Tdap every 10 years Other adult vaccinations Consider varicella, hepatitis A, hepatitis B, measles-mumps-rubella, meningococcal ACWY and meningococcal B vaccines depending on age and risk factors -
Screening Recommendations for Males: 18-39 Years
Screening, immunization, and prevention schedule for asymptomatic average-risk men: 18-39 Years
These screening recommendations are driven by Mayo Clinic consensus and incorporate — but do not exactly replicate — screening guidelines from the U.S. Preventive Services Task Force and other organizations.
Screening Recommendations Alcohol abuse Every year Colorectal cancer Begin if increased risk Depression Every year Diabetes (Type 2) Every 3 years if hypertension or BMI > 25 (BMI > 23 in Asian patients) Hepatitis C One-time screen for all adults ages 18 to 79 years HIV At least one lifetime screen for all age groups Hyperlipidemia (coronary artery disease) Screen initially at age 20 years, then resume no later than age 40 years Hypertension Every 2 years Intimate partner violence Every year Obesity Every 2 years Tobacco use Every year Vaccinations for healthy men COVID-19 Primary series and bivalent booster Hepatitis B Everyone through age < 59; consider for age > depending on risk factors Human papillomavirus (HPV) Initiate series for adults up through age 26 years, consider series initiation for ages 27 through 45 years based on shared decision-making Influenza Every year Tetanus, diphtheria, acellular pertussis (Tdap and Td) If primary series of Tdap/DTaP has been completed at any age, boost with Tdap every 10 years Other adult vaccinations Consider varicella, hepatitis A, hepatitis B, measles-mumps-rubella, meningococcal ACWY and meningococcal B vaccines depending on age and risk factors -
Screening Recommendations for Males: 40-49 Years
Screening, immunization, and prevention schedule for asymptomatic average-risk men: 40-49 Years
These screening recommendations are driven by Mayo Clinic consensus and incorporate — but do not exactly replicate — screening guidelines from the U.S. Preventive Services Task Force and other organizations.
Screening Recommendations Alcohol abuse Every year Colorectal cancer If age < 45 years,consider if increased risk
Consider beginning screening of average-risk patients at age 45 years
Depression Every year Diabetes Every 3 years beginning at age 45 years Hepatitis B Screen all patients at high risk of infection, including those previously vaccinated Hepatitis C One-time screen for all adults ages 18 to 79 years HIV At least one lifetime screen for all age group Hyperlipidemia (coronary artery disease) Every 4 to 6 years Hypertension Every year Intimate partner violence Every year Obesity Every 2 years Tobacco use Every year Vaccinations for healthy men COVID-19 Primary series and bivalent booster Hepatitis B Everyone through age < 59; consider for age > depending on risk factors Influenza Every year Tetanus, diphtheria, acellular pertussis (Tdap and Td) If primary series of Tdap/DTaP has been completed at any age, boost with Tdap every 10 years Other adult vaccinations Consider varicella, hepatitis A, hepatitis B, measles-mumps-rubella, meningococcal ACWY and meningococcal vaccines depending on age and risk factors -
Screening Recommendations for Males: 50-64 Years
Screening, immunization, and prevention schedule for asymptomatic average-risk men: 50-64 Years
These screening recommendations are driven by Mayo Clinic consensus and incorporate — but do not exactly replicate — screening guidelines from the U.S. Preventive Services Task Force and other organizations.
Screening Recommendations Alcohol abuse Every year Colorectal cancer Continue average-risk screening Depression Every year Diabetes (Type 2) Every 3 years Hepatitis C One-time screen for all adults age 18 to 79 years HIV At least one lifetime screen for all age groups Hyperlipidemia (coronary artery disease) Every 4 to 6 years Hypertension Every year Intimate partner violence Every year Obesity Every 2 years Prostate cancer Consider shared decision-making Tobacco use Every year Vaccinations for healthy men COVID-19 Primary series and bivalent booster Hepatitis B Everyone through age < 59; consider for age > depending on risk factors Herpes zoster or shingles (HZV) 2 doses of Shingrix (regardless of previous Zostavax) at age > 50 years unless contraindicated Influenza Every year Tetanus, diphtheria, acellular pertussis (Tdap and Td) If primary series of Tdap/DTaP has been completed at any age, boost with Tdap every 10 years Other adult vaccinations Consider varicella, hepatitis A, hepatitis B, measles-mumps-rubella, meningococcal ACWY and meningococcal B vaccines depending on age and risk factors -
Screening Recommendations for Males: 65 and older
Screening, immunization, and prevention schedule for asymptomatic average-risk men: 50-64 Years
These screening recommendations are driven by Mayo Clinic consensus and incorporate — but do not exactly replicate — screening guidelines from the U.S. Preventive Services Task Force and other organizations.
Screening Recommendations Abdominal aortic aneurysm If smoking history, one-time screen between ages 65 and 75 and beyond if life expectancy > 10 years Alcohol abuse Every year Colorectal cancer Ages 65 to 75 years (life expectancy > 10 years): Continue screening
Ages 76 to 85 years (life expectancy > 10 years): Screen patients who have never been screened; continued screening of other patients has uncertain benefit
Depression Every year Diabetes (Type 2) Every 3 years Fall risk Every year Hepatitis C One-time screen for all adults born from 1945 to 1965 HIV One-time screen for all age groups Hyperlipidemia (coronary artery disease) Ages 65 to 75 years: Consider every 4 to 6 years Hypertension Every year Intimate partner violence Every year Obesity Every 2 years Prostate cancer Consider shared decision-making Tobacco use Every year Vaccinations for healthy men COVID-19 Primary series and bivalent booster Hepatitis B Everyone through age < 59; consider for age > 60 depending on risk factors Herpes zoster or shingles (HZV) 2 doses of Shingrix (regardless of previous Zostavax) at age > unless contraindicated Influenza Every year Pneumococcal One-time dose of PCV20 at age 65 if no previous pneumococcal vaccination. If previous pneumococcal vaccination received, discuss with clinician Tetanus, diphtheria, acellular pertussis (Tdap and Td) If primary series of Tdap/DTaP has been completed at any age, boost with Tdap every 10 years Other adult vaccinations Consider varicella, hepatitis A, hepatitis B, measles-mumps-rubella, meningococcal ACWY and meningococcal B vaccines depending on age and risk factors